Cysteamine eye drops in the treatment of cystinosis – an Australian perspective

E-ISSN： 2055-2335|45|4|440-445

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.45, Iss.4, 2015-12, pp. : 440-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacological treatment of nephropathic cystinosis with cysteamine

By Kleta Robert Gahl William A

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 11, 2004-11 ,pp. : 2255-2262

Informa Healthcare

Access to resources Recommend Favorite

The influence of penetration enhancers on the volume instilled of eye drops

By Van Santvliet L. Ludwig A.

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 45, Iss. 2, 1998-03 ,pp. : 189-198

Elsevier

Access to resources Recommend Favorite

Chemical Stability of Voriconazole 1% Eye Drops

JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 38, Iss. 3, 2008-09 ,pp. : 179-182

John Wiley & Sons Inc

Access to resources Recommend Favorite

The Role of Atropine Eye Drops in Myopia Control

Current Pharmaceutical Design, Vol. 21, Iss. 32, 2015-10 ,pp. : 4718-4730

Bentham Science Publishers

Access to resources Recommend Favorite

Proxymetacaine eye drops reduce pain in infants during eye examinations

Inpharma, Vol. 1, Iss. 1496, 2005-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite